Safety remains our key priority. COVID-19 vaccines undergo the same rigorous studies, approval process and objective review by the EMA and other global regulators, as any vaccine. We will never compromise on safety.
The progressive nature of Spinal Muscular Atrophy (SMA) means that the sooner someone is diagnosed; the sooner intervention can be made with treatments that can change the course of the disease.
This special report on pain features Grünenthal, who sees palliative care as a moral duty and human right and believes that end of life care should be achievable and accessible worldwide. Grünenthal has developed comprehensive care systems that include psychological, spiritual and social support for the patient and their families.
Leo Pharma works in partnership with patients to gain a better understanding of diseases and chronic conditions, and the treatment plan that is needed. The company feels it is vital for patients to be involved in all the key steps as nobody is more informed than someone living with the condition.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.